FDA Plans Panel Review For Essure Birth Control In Response To Patient Complaints
This article was originally published in The Gray Sheet
Executive Summary
The agency says it has met with patients and patient advocates about complaints, device removal challenges and other issues with Bayer's Essure female sterilization system, leading to an FDA review of safety reports and a panel date scheduled for September.